How the Hell do I Prioritize Work, Blog & Find Balance?

Both Sides of the Table

I don’t know Ezra yet but since he’s taking the time to blog (which I hugesly respect) and share thoughts I thought I’d take him up on his challenge and also spill the beans on my secrets. On blogging I blog because I love it. My other secret on blogging?

Why Startups Need to Blog (and what to talk about …)

Both Sides of the Table

Blogs. By definition, you read blogs. People often ask me why I started blogging. I know that I have not yet earned these kudos based on investment returns (although my partners have. My suggestion is to blog about your industry. Blog on that topic.

Interesting New Tech Blog for your Radar Screen

Both Sides of the Table

Over the holiday I became aware of a new tech blog that aims to have deep insights into the next generation of technology, which they call The Hypernet. My favorite post was this one (image above) in which they talked about their 10 hypothesis for technology investing.

About this Blog

SoCal CTO

skip to main | skip to sidebar SoCal CTO Saturday, February 17, 2007 About this Blog Ive been thinking about doing a blog with my thoughts on technology and whats happening in the Los Angeles area technology scene for a while, but it was Ben Kuos recent start of a blog that inspired me to actually go ahead and do it. Where LinkedIn Works for Me A Different Kind of Incubator - The Hive About this Blog Southern California Tech Central Southern California Tech Central Loading

Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns

Xconomy

One size fits most (at best), and a women’s sizing system created during the Depression doesn’t gibe in an e-commerce business that prizes personalization.

Seed-Stage Deals Show Growing Diversity of Agtech Investments

Xconomy

Fundraising is tough for startups but it’s particularly difficult in agriculture, a sector that has fewer firms focused on agtech investments. While the total dollars invested in 2016 decreased by nearly 30 percent year over year, the total number of deals increased by 10 percent.

Billie, Subscription Shaving Products Service for Women, Raises $25M

Xconomy

The New York-based startup said Tuesday that the new funding round, which is being led by Goldman Sachs Private Capital Investing group, brings its total investment to $35 million.

Mail.com Buys Entertainment Blog

socalTECH

Los Angeles-based Mail.com Media Corporation , which operates the email service Mail.com, said today that it has acquired an entertainment focused blog, DeadlineHollywoodDaily.com. The company is backed by Quadrangle Capital Partners, which invested $35M in the firm back in October of last year. Tags: mail.com mail media merger acquisition deadlinehollywooddaily blog content email

Finding True Love Can Be Ruff, But This Startup Could Have Your Match

Xconomy

Too many people treat pet adoption like a one-night stand. You look at a dog, and see his eyes, and think he’s cute,” says Tama Lundquist, co-president of Houston PetSet, an organization that works with about 70 animal shelters in the Houston area.

Saxena: More Than a Tool, A.I. Must Be Used With Society in Mind

Xconomy

startup CognitiveScale and managing director of The Entrepreneur Fund , which makes investments in early-stage machine learning companies, Saxena believes A.I. [ Updated 12/27/18, 9:54 am ] Manoj Saxena is bullish on artificial intelligence. As chairman of Austin, TX-based A.I.

Tool 107

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out. I had kept a personal blog for more than a year and was new at keeping a professional blog. Remember, I was new to professional blogging.

Chris Sacca Retires from Startup Investing

L.A. Business Journal

Prominent seed-stage startup investor Chris Sacca announced in a blog post titled “Hanging up my spurs” on Wednesday that he has retired from venture capital investing

Invest 149

From Immigration to Taxes, Execs Talk Trump Effect on Innovation

Xconomy

When it comes to developing and promoting innovation, external factors beyond the control of company founders, investors, and other business leaders can also determine whether a startup succeeds or fails.

.Net 103

Chartbeat is to Blogs as Google Analytics is to Print Newspapers

Both Sides of the Table

I’ve been using Chartbeat for over a month now to track performance of my blog and I find myself looking at Google Analytics much less these days. I’m not a shareholder and I’m not even actively looking at making an investment.

Public and Open Debate is the Highest Form of Democracy (and Blogging)

Both Sides of the Table

And there is relationship between debating and blogging. I started blogging in 2005 and then re-started blogging about a year ago. The most important experience I have in blogging is the debate it encourages. So it goes with blogging. So it goes on my blog.

Big Deals, Life Sciences Push U.S. VC in 2018 to Dot-Com Boom Levels

Xconomy

Venture capital investments rose in 2018 to levels not seen since the heady days of 2000, the last year U.S. That was about 500 fewer deals than in the year prior, but the total amount invested increased by $47.9

Pensa, AI-Enabled Drones Maker for Inventory Monitoring, Raises $5M

Xconomy

Austin —The grocery store shelf has yet to be plugged into the increasingly digital food supply chain. Instead, inventory is typically tallied by employees by hand in a slow and laborious process. “It’s It’s one big black hole with groceries, not knowing what is exactly on the retail shelf and available for sale,” says Richard Schwartz, president and CEO of Pensa Systems in Austin. Something like one out of eight or 10 items is typically not in stock.”

Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More

Xconomy

The flow of biotech news is particularly heavy today, and for good reason. The annual J.P. Morgan Healthcare Conference, one of the biggest gatherings for the biopharmaceutical industry, kicked off today in San Francisco, and many companies, whether they’re speaking at the event or not, use this time to get their news out. Xconomy is on the ground covering the conference this week. In the meantime, here’s a short roundup of biotech news announced today.

News 67

Finistere Plants Investment Seed in Ireland With $24M Agtech Fund

Xconomy

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland. Ireland’s top agricultural exports are beef and dairy products.

Room Service by Robot And Other Ways Tech is Changing The Hotel Stay

Xconomy

More days than not, Michael Colaneri’s home is a hotel room. So innovations like “geolocation” sensors that automatically unlock his room door and adjust the thermostat when he’s nearby make the constant change easier—sometimes. “My My experience has been exceptionally inconsistent,” he says.

How the Rise of Beijing and Shanghai Tech May Impact Silicon Valley

Xconomy

Boston blog main Boston top stories Boulder/Denver blog main Detroit blog main Indiana blog main National blog main National top stories New York blog main New York top stories Raleigh-Durham blog main San Diego blog main San Francisco San Francisco blog main San Francisco top stories Seattle blog main Texas blog main Texas top stories Wisconsin blog main Asia Asian investment austin Beijing Berlin Blair Garrou Boston CB Insights China Didi ele.me

Plant-Based Burger Maker Beyond Meat Cooks Up Plans for an IPO

Xconomy

We’ll soon find out if Wall Street has the appetite for investing in alternative meat technology. Beyond Meat, a maker of plant-based meat products, has filed for an IPO.

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

Xconomy

The growing epidemic of the fatty liver disease known as NASH, which has no FDA-approved treatment, has led to a frenzied race among drug companies. This week, one company, Intercept Pharmaceuticals, solidified its lead. But how much will being first to the finish line mean when all is said and done? Intercept (NASDAQ: ICPT ) reported interim data from a Phase 3 study showing its drug, obeticholic acid (OCA), reduced liver scarring in NASH patients.

News 66

Pineapples and Bananas: Yummy to Eat, And Now Fashionable to Wear

Xconomy

Style trends may come and go but the apparel industry is increasingly accepting that sustainability will always be in fashion. “We

Farm Startup Bowery Lands $90M to Take Indoor-Grown Greens National

Xconomy

Foodies in New York City may not realize it, but some of the tasty kale, bok choy, and other leafy greens they buy trace their origins to an industrial park in New Jersey.

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Xconomy

Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests of its AI-powered technology. The cash tops off a Series B round of funding announced last year.

Study 75

Former Biotech VC Steven Burrill Draws 30-Month Prison Term for Fraud

Xconomy

Steven Burrill, once a noted biotech investment fund founder, sought-after conference speaker, and life sciences publisher, was sentenced Wednesday to serve 30 months in federal prison for defrauding his investors and evading taxes.

Henry Blodget Loves to Blog: The remaking of a disgraced Wall Street analyst

From the Venture Trenches

This was in direct response to the implosion of the tech bubble and the fall out of Enron, Worldcom and the questionable research produced by the investment banks in general and Blodget in particular.

Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More

Xconomy

Pharmaceutical companies typically raise prescription drug prices at the start of each year and this year was no different. The increases were the latest reminder that, despite President Trump’s fiery campaign rhetoric, the administration had done little to actually lower drug prices. But a new plan aimed at the secretive rebate deals between pharma companies and pharmacy benefit managers could change things.

Next Coast Ventures Latest Addition to Austin’s Investment Ecosystem

Xconomy

Austin —Mike Smerklo, co-founder of Next Coast Ventures in Austin, says his venture firm brings a key ingredient to investing: entrepreneurial experience. “We Smerklo says the firm will largely focus on Austin startups, making Series A and B investments in tech companies innovating in.

Hungry for Innovation, Big Food Firms Seek Alliances With Startups

Xconomy

The firms include stalwarts like Kraft Heinz (NASDAQ: KHC ) , which has an incubator and accelerator program called Springboard , and relative newcomers like the Greek-style yogurt maker Chobani , which operates an incubator that makes $25,000 investments in startups with no equity stake.

Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More

Xconomy

While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion , it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker. In the early 2000s, before the FDA approved Celgene’s flagship multiple myeloma drug lenalidomide (Revlimid), Novartis (NYSE: NVS considered buying the company. It passed, unwilling to risk billions on an unapproved drug.

Apple Plans 5,000 Jobs for New Austin Site as Part of Nationwide Expansion

Xconomy

Austin —Apple expects to make thousands of new hires around the country from Seattle to New York, the company announced Thursday, with its biggest growth planned for Austin, TX.

Sites 81

Graphcore Scores $200M to Scale Up A.I. Chip Production

Xconomy

One of the leading contenders in the A.I. chip race, Graphcore , announced Thursday it pulled down $200 million in a Series D fundraising round that set its valuation at $1.7 billion.

How Do I Feel About the Snap IPO Given I Didn’t Invest?

Both Sides of the Table

Every tech or major news journal in the country is preparing to write their Snap, Inc (creators of Snapchat, Spectacles, etc) stories and many of them seem to want a “How does it feel to have missed this investment story.” But local VCs don’t deserve to get beat up for not investing.

Invest 283